Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
2003 National Healthcare Quality Report

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

Table 1.38b: Treatment of AMI by State

Percent of AMI patients with left ventricular systolic dysfunction prescribed ACE inhibitor at discharge, by State, 2000-2001a
     
State Percent Standard error
United States 73.91 1.08
Alabama 69.16 4.51
Alaska 100.00 0.00
Arizona 69.41 5.06
Arkansas 68.75 4.78
California 70.11 4.96
Colorado 81.94 4.60
Connecticut 80.39 3.97
Delaware 81.82 4.82
District of Columbia 78.31 4.58
Florida 60.22 5.13
Georgia 71.08 5.04
Hawaii 79.17 5.99
Idaho 77.55 6.08
Illinois 73.42 5.03
Indiana 79.07 4.44
Iowa 77.11 4.67
Kansas 67.07 5.25
Kentucky 66.33 4.82
Louisiana 65.33 5.57
Maine 82.09 4.76
Maryland 78.67 4.79
Massachusetts 71.58 4.68
Michigan 82.29 3.94
Minnesota 68.82 4.86
Mississippi 66.25 5.35
Missouri 74.04 4.34
Montana 71.43 7.14
Nebraska 80.61 4.03
Nevada 73.33 5.81
New Hampshire 87.10 4.33
New Jersey 64.10 5.50
New Mexico 66.67 5.41
New York 76.25 4.82
North Carolina 76.14 4.60
North Dakota 64.47 5.56
Ohio 64.44 5.10
Oklahoma 75.58 4.69
Oregon 78.13 5.25
Pennsylvania 62.92 5.18
Puerto Rico 64.47 5.56
Rhode Island 84.38 4.61
South Carolina 78.46 5.18
South Dakota 75.00 4.78
Tennessee 70.97 4.76
Texas 63.51 5.67
Utah 77.97 5.49
Vermont 69.64 6.26
Virginia 77.53 4.47
Washington 70.73 5.09
West Virginia 65.38 5.46
Wisconsin 75.00 4.67
Wyoming 88.89 11.79

a Population is Medicare patients only.

Source:  Centers for Medicare and Medicaid Services, Medicare Quality Improvement Organization Program.

Table 1.38a: National Treatment of AMI Table 1.39a: National Treatment of AMI

Return to Tables Appendix
Return to Contents

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care